AJCN 19th International Congress of Nutrition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwarz, J.-M.
Right arrow Articles by Aghajanian, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwarz, J.-M.
Right arrow Articles by Aghajanian, K.
Agricola
Right arrow Articles by Schwarz, J.-M.
Right arrow Articles by Aghajanian, K.
American Journal of Clinical Nutrition, Vol. 77, No. 1, 43-50, January 2003
© 2003 American Society for Clinical Nutrition


Original Research Communications

Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets1,2,3

Jean-Marc Schwarz, Peter Linfoot, Doris Dare and Karmen Aghajanian

1 From the Department of Nutritional Sciences and Toxicology, University of California, Berkeley (J-MS and KA), and the Department of Medicine, University of California, San Francisco (J-MS, PL, and DD).

Background: Hypertriglyceridemia is associated with increased risk of cardiovascular disease. Until recently, the importance of hepatic de novo lipogenesis (DNL) in contributing to hypertriglyceridemia was difficult to assess because of methodologic limitations.

Objective: We evaluated the extent of the contribution by DNL to different conditions associated with hypertriglyceridemia.

Design: After 5 d of an isoenergetic high-fat, low-carbohydrate diet, fasting DNL was measured in normoinsulinemic (<= 85 pmol/L) lean (n = 9) and obese (n = 6) and hyperinsulinemic (>= 115 pmol/L) obese (n = 8) subjects. Fasting DNL was measured after a low-fat, high-carbohydrate diet in normoinsulinemic lean (n = 5) and hyperinsulinemic obese (n = 5) subjects. Mass isotopomer distribution analysis was used to measure the fraction of newly synthesized fatty acids in VLDL-triacylglycerol.

Results: With the high-fat, low-carbohydrate diet, hyperinsulinemic obese subjects had a 3.7–5.3-fold higher fractional DNL (8.5 ± 0.7%) than did normoinsulinemic lean (1.6 ± 0.5%) or obese (2.3 ± 0.3%) subjects. With the low-fat, high-carbohydrate diet, normoinsulinemic lean and hyperinsulinemic obese subjects had similarly high fractional DNL (13 ± 5.1% and 12.8 ± 1.4%, respectively). Compared with baseline, consumption of the high-fat, low-carbohydrate diet did not affect triacylglycerol concentrations. However, after the low-fat, high-carbohydrate diet, triacylglycerols increased significantly and DNL was 5–6-fold higher than in normoinsulinemic subjects consuming a high-fat diet. The increase in triacylglycerol after the low-fat, high-carbohydrate diet was correlated with fractional DNL (P < 0.01), indicating that subjects with high DNL had the greatest increase in triacylglycerols.

Conclusions: These results support the concept that both hyperinsulinemia and a low-fat diet increase DNL, and that DNL contributes to hypertriglyceridemia.

Key Words: Obesity • hyperinsulinemia • hepatic de novo lipogenesis • triacylglycerols • triglycerides • hypertriglyceridemia • hyperlipidemia • cardiovascular disease • heart disease




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
N. Stefan, K. Kantartzis, and H.-U. Haring
Causes and Metabolic Consequences of Fatty Liver
Endocr. Rev., December 1, 2008; 29(7): 939 - 960.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. E. Smith, K. L. Tucker, N. Yiannakouris, B. Garcia-Bailo, J. Mattei, C.-Q. Lai, L. D. Parnell, and J. M. Ordovas
Perilipin Polymorphism Interacts with Dietary Carbohydrates to Modulate Anthropometric Traits in Hispanics of Caribbean Origin
J. Nutr., October 1, 2008; 138(10): 1852 - 1858.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Radenne, M. Akpa, C. Martel, S. Sawadogo, D. Mauvoisin, and C. Mounier
Hepatic regulation of fatty acid synthase by insulin and T3: evidence for T3 genomic and nongenomic actions
Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E884 - E894.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Anderson and J. Borlak
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Pharmacol. Rev., September 1, 2008; 60(3): 311 - 357.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Begriche, P. Letteron, A. Abbey-Toby, N. Vadrot, M.-A. Robin, A. Bado, D. Pessayre, and B. Fromenty
Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice
Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E939 - E951.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. F-F Chong, L. Hodson, A. S Bickerton, R. Roberts, M. Neville, F. Karpe, K. N Frayn, and B. A Fielding
Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 817 - 823.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. Roberts, A. S Bickerton, B. A Fielding, E. E Blaak, A. J Wagenmakers, M. F-F Chong, M. Gilbert, F. Karpe, and K. N Frayn
Reduced oxidation of dietary fat after a short term high-carbohydrate diet
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 824 - 831.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Hebbachi, B. L. Knight, D. Wiggins, D. D. Patel, and G. F. Gibbons
Peroxisome Proliferator-activated Receptor {alpha} Deficiency Abolishes the Response of Lipogenic Gene Expression to Re-feeding: RESTORATION OF THE NORMAL RESPONSE BY ACTIVATION OF LIVER X RECEPTOR {alpha}
J. Biol. Chem., February 22, 2008; 283(8): 4866 - 4876.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. M Zivkovic, J B. German, and A. J Sanyal
Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease
Am. J. Clinical Nutrition, August 1, 2007; 86(2): 285 - 300.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Vedala, W. Wang, R. A. Neese, M. P. Christiansen, and M. K. Hellerstein
Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans
J. Lipid Res., November 1, 2006; 47(11): 2562 - 2574.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
E. J. Parks and M. K. Hellerstein
Thematic review series: Patient-Oriented Research. Recent advances in liver triacylglycerol and fatty acid metabolism using stable isotope labeling techniques
J. Lipid Res., August 1, 2006; 47(8): 1651 - 1660.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Dentin, F. Benhamed, I. Hainault, V. Fauveau, F. Foufelle, J. R.B. Dyck, J. Girard, and C. Postic
Liver-Specific Inhibition of ChREBP Improves Hepatic Steatosis and Insulin Resistance in ob/ob Mice.
Diabetes, August 1, 2006; 55(8): 2159 - 2170.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Duez, B. Lamarche, K. D. Uffelman, R. Valero, J. S. Cohn, and G. F. Lewis
Hyperinsulinemia Is Associated With Increased Production Rate of Intestinal Apolipoprotein B-48-Containing Lipoproteins in Humans
Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1357 - 1363.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. N. Ginsberg
REVIEW: Efficacy and Mechanisms of Action of Statins in the Treatment of Diabetic Dyslipidemia
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 383 - 392.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. T. Timlin, B. R. Barrows, and E. J. Parks
Increased Dietary Substrate Delivery Alters Hepatic Fatty Acid Recycling in Healthy Men
Diabetes, September 1, 2005; 54(9): 2694 - 2701.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
X. Lin, P. Yue, Y. Xie, N. O. Davidson, N. Sakata, R. E. Ostlund Jr., Z. Chen, and G. Schonfeld
Reduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncation
Am J Physiol Gastrointest Liver Physiol, July 1, 2005; 289(1): G146 - G152.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. T Timlin and E. J Parks
Temporal pattern of de novo lipogenesis in the postprandial state in healthy men
Am. J. Clinical Nutrition, January 1, 2005; 81(1): 35 - 42.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
J. Mercola
Managing hypertriglyceridemia
Can. Med. Assoc. J., April 1, 2003; 168(7): 831 - 832.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by The American Society for Nutrition